Researchers to test novel drug combination against toughest breast cancers
Researchers at University of California San Diego School of Medicine have launched a phase Ib clinical trial to assess the safety and tolerability of cirmtuzumab, in combination with standard chemotherapy, to treat metastatic ...
Aug 27, 2018
0
35